Epilepsy, Tonic-clonic Clinical Trial
Official title:
A Multicenter, Double-blind, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam (1000 to 3000 mg/Day Oral b.i.d.) and Carbamazepine (400 to 1200 mg/Day Oral b.i.d.), Used as Monotherapy in Subjects (≥ 16 Years) Coming From the N01061 Trial.
A double-blind follow-up trial assessing the long term safety of Levetiracetam as per adverse events reporting, physical and neurological examination and vital signs
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04770337 -
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
|
N/A | |
| Terminated |
NCT03831802 -
Embrace and Quality of Life
|
N/A | |
| Withdrawn |
NCT04282681 -
XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)
|
||
| Completed |
NCT01439438 -
Topiramate Bioequivalence Study Brazil - Fast
|
Phase 1 | |
| Completed |
NCT00231556 -
A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy
|
Phase 3 | |
| Completed |
NCT03446664 -
Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
|
N/A | |
| Completed |
NCT00104416 -
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures
|
Phase 3 | |
| Completed |
NCT00043901 -
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
|
Phase 4 | |
| Completed |
NCT00150813 -
Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.
|
Phase 3 |